Published on
Last updated on
Cisema Webinar with US's AdvaMed: Opportunities and Regulatory Implications in China's Digital Healthcare Economy
On May 25, 2021, Cisema and Advamed will cohost a webinar on China’s digital healthcare economy and relevant regulatory framework.
Mr. Hamish King, Chief Operating Officer of Cisema, will lead the discussion to present on the market opportunities and regulatory implications of the fast-growing digital healthcare sector in China. Covid-19 has only served to further accelerate favorable market tailwinds. Telehealth, AI and other key digital health trends in China will be discussed, and the regulatory framework analyzed.
Cisema Webinar: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy
Date: May 25, 2021
Time: 11:00 PM – 12:00 PM (HKT)
Registration Link: TBA
Agenda topics will include:
1. Digital Healthcare sector in China and recent updates
2. Regulatory pathways for medical devices and IVDs with the China National Medical Products Administration (NMPA, formerly CFDA)
3. Cyber security
4. SaMD registration in China
5. Alternative regulatory pathways
6. Q&A
Be sure to stay till the end where our Cisema’s experts will answer your questions that could help equip you to access China’s digital health market.
Related News
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.